Can visual assessment of blood flow patterns by dynamic contrast-enhanced computed tomography distinguish between malignant and benign lung tumours?

Autor: Jesper Thygesen, Hans Henrik Torp Madsen, Henrik Hager, Stefan Walbom Harders, Torben Riis Rasmussen, Hanne Marie Nellemann, Finn Rasmussen, Niels Trolle Andersen
Jazyk: angličtina
Rok vydání: 2017
Předmět:
Zdroj: Harders, S W, Madsen, H H T, Nellemann, H M, Rasmussen, T R, Thygesen, J, Hager, H, Andersen, N T & Rasmussen, F 2017, ' Can visual assessment of blood flow patterns by dynamic contrast-enhanced computed tomography distinguish between malignant and benign lung tumours? ', Acta Radiologica Open, vol. 6, no. 5, 2058460117710053 . https://doi.org/10.1177/2058460117710053
Harders, S W, Madsen, H H, Nellemann, H M, Rasmussen, T R, Thygesen, J, Hager, H, Andersen, N T & Rasmussen, F 2017, ' Can visual assessment of blood flow patterns by dynamic contrast-enhanced computed tomography distinguish between malignant and benign lung tumors? ', Acta Radiologica Open, vol. 6, no. 5, 2058460117710053 . https://doi.org/10.1177/2058460117710053
Acta Radiologica Open
DOI: 10.1177/2058460117710053
Popis: Background Dynamic contrast-enhanced computed tomography (DCE-CT) is a tool, which, in theory, can quantify the blood flow and blood volume of tissues. In structured qualitative analysis, parametric color maps yield a visual impression of the blood flow and blood volume within the tissue being studied, allowing for quick identification of the areas with the highest or lowest blood flow and blood volume. Purpose To examine whether DCE-CT could be used to distinguish between malignant and benign lung tumors in patients with suspected lung cancer. Material and Methods Fifty-nine patients with suspected lung cancer and a lung tumor on their chest radiograph were included for DCE-CT. The tumors were categorized using structured qualitative analysis of tumor blood flow patterns. Histopathology was used as reference standard. Results Using structured qualitative analysis of tumor blood flow patterns, it was possible to distinguish between malignant and benign lung tumors (Fisher–Freeman–Halton exact test, P = 0.022). The inter-reader agreement of this method of analysis was slight to moderate (kappa = 0.30; 95% confidence interval [CI] = 0.13–0.46). Conclusion DCE-CT in suspected lung cancer using structured qualitative analysis of tumor blood flow patterns is accurate as well as somewhat reproducible. However, there are significant limitations to DCE-CT.
Databáze: OpenAIRE